Pfizer: Malaria, Falciparum trials
The registry lists 10 Malaria, Falciparum studies with Pfizer as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 2Phase 2 7Phase 3 5Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In AfricaCompletedNCT00677833Phase 2/3Results posted
- A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum MalariaCompletedNCT00282919Phase 2Results posted
- A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy SubjectsCompletedNCT00894660Phase 1
- Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy SubjectsCompletedNCT00894374Phase 1
- A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy SubjectsCompletedNCT00859807Phase 4
- Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaTerminatedNCT00084240Phase 2/3
- Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South AmericaCompletedNCT00084227Phase 2/3
- Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in AfricaCompletedNCT00082576Phase 2/3
- Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium FalciparumTerminatedNCT00082563Phase 2
- Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in IndiaCompletedNCT00074841Phase 2/3